Intuit has signed an agreement to acquire Sequence, a startup that sells software for managing revenue, the company said on October 15, 2026. Intuit described Sequence as an AI-native revenue management platform and as a Series A company. It did not disclose the price or other financial terms, and it did not give a closing date.
Sequence's chief executive and co-founder, Riya Grover, will join Intuit's Mid-Market product organization. Intuit said it will keep supporting Sequence's customers and will make the startup's capabilities available after the deal closes, and that it plans to develop an integrated offering "in the coming months".
The purchase extends Intuit's revenue management capabilities and is aimed at its mid-market products, which the company named as Intuit Enterprise Suite and QuickBooks Online Advanced.
What Sequence built
Sequence was founded in 2021. Intuit's announcement says the company is based in London and New York; later press coverage of its funding round described it as New York based. Grover is the only founder named in the sources reviewed, and the company has described its founding team as repeat, exited founders without naming the others.
Its product covers what finance teams call the contract-to-cash cycle: reading contracts, billing, collecting payment and recognising revenue. When it announced its Series A in December 2025, Sequence said it ran three AI agents, one for contracts, one for chasing overdue payments (dunning) and one for reviewing invoices, plus a monitoring screen it called a watchtower, which lets finance staff see what the agents are doing.
At that time the company said it had more than 100 customers, among them Incident.io, Bridge, Legora, Runway, Cognition, 11x, Raspberry AI, Moonpay and Bill.com. It also said it automated more than $1 billion in annual invoice volume and had grown annual recurring revenue tenfold over the previous year. Those figures are the company's own claims from December, and Intuit's announcement did not update them.
“Finance teams spend too much time on spreadsheets and manual workarounds”
Why Intuit is buying
Intuit's stated reason is that mid-sized businesses need revenue management and revenue recognition tools as they outgrow basic accounting software. Wyatt Jenkins, senior vice president of product for Intuit's Mid-Market Group, told CFO Dive that "revenue management and revenue recognition are critical factors when choosing an ERP", the enterprise resource planning systems that run a company's finances.
Ashley Still, Intuit's executive vice president and general manager of the Small Business & Mid-Market Group, said in the announcement that "Sequence will let us deliver mature revenue management to customers".
Usage-based and hybrid pricing, which many software companies now use, makes revenue recognition harder than a flat monthly fee, and Sequence has pitched its agents at that complexity. Grover said in the announcement that complexity keeps growing as businesses adopt such pricing models.
The founders and the funding
Sequence announced a $20 million Series A on December 17, 2025, led by 645 Ventures. Andreessen Horowitz (a16z), Firstminute Capital, Passion Capital, Dig Ventures and Vor Capital also took part, and chief financial officers at Decagon, Klaviyo and Wise joined the round. The company said it had raised $40 million in total by then.
The sources reviewed do not say how much of the earlier $20 million was a seed round, who led it, or how many people work at Sequence. Intuit's release did not say whether Sequence's staff beyond Grover will move to Intuit.
What happens to customers
For now Sequence's customers are told to expect continuity. Intuit said it will support them and then fold the capabilities into its own offering, but it gave no timetable for retiring or renaming the Sequence product, and no details on pricing or contracts.
Grover said finance teams spend too much time on spreadsheets and manual workarounds, the problem Sequence was built to remove, according to CFO Dive. The deal is subject to closing, and the sources reviewed do not describe the conditions or any regulatory approvals required.
